Frazier Lifesciences Acquisition - Warrants (09/12/2025) Common Stock

As of the most recent data (September 2022), FLACW shows a common stock of $280M. That compares with $140M in the prior-year period — up 101.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FLACW's common stock is now $280M (was $140M) — a 101.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Frazier Lifesciences Acquisition - Warrants (09/12/2025) is outperforming or lagging.

Tracking FLACW's common stock over time shows whether Frazier Lifesciences Acquisition - Warrants (09/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $280M That compares with $140M in the prior-year period — up 101.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $280M) with ownership activity and broader fundamentals.